GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Science, American Association for the Advancement of Science (AAAS), Vol. 381, No. 6662 ( 2023-09-08)
    Abstract: The local environment is critical for establishing the phenotype of macrophages within a given organ. In the liver, resident macrophages reach out of the sinusoids to receive instructive cues in a niche composed of hepatocytes, endothelial cells, and stellate cells. These cues activate specific transcription factors, which endow these macrophages with Kupffer cell (KC) “identity.” In the sinusoids, KCs perform the critical function of capturing pathogens from the blood by means of specialized receptors, including the complement receptor CRIg. Liver fibrosis and cirrhosis is the common end-stage of various chronic liver diseases, leading to substantial morbidity and mortality in affected individuals. Despite different etiologies, progression is similar, with hepatocyte death and collagen deposition around sinusoids, resulting in the redistribution of blood flow to new and expanded intrahepatic and extrahepatic collateral vessels. RATIONALE It remains unclear how fibrotic remodeling of the niche environment affects the KC compartment. In this study, we used various lineage-tracing models and intravital microscopy to visualize, track, and functionally assess monocytes and KCs in the fibrotic liver environment. RESULTS Using the most common mouse model of liver fibrosis—carbon tetrachloride toxicity—we observed profound architectural changes in the liver. This remodeling included a massive increase in collateral vessels and collagen deposition around the sinusoids, which caused KCs to lose contact with their surrounding environment. This, in turn, led to the down-regulation of key transcription factors and membrane proteins such as CLEC4F, CRIg, and TIM-4, which collectively determine KC identity. Although these changes resulted in impaired KC function, the liver continued to act as a major filter of blood-borne bacteria despite the loss of KC identity. An abundance of monocytes were recruited, and these cells primarily adhered to large intrahepatic vessels through CD44 owing to increased endothelial cell adhesivity driven by intestinal microbiota. Monocytes formed large clusters within the collateral vessels and began to express KC markers. These monocytes made up a spectrum of structures ranging from clusters of individual cells to fused multinucleated giant cells that collectively appeared as KC-like syncytia. Although individual KCs could not catch bacteria flowing within larger vessels, KC-like syncytia were able to capture high numbers of circulating bacteria. Using transcriptomic analysis, we identified CD36 as the key molecule underlying syncytial fusion and reduced susceptibility to infection. CRIg-expresssing intravascular macrophage syncytia were also found in human cirrhosis of different etiology. CONCLUSION Loss of contact with parenchymal cells in the fibrotic niche leads sinusoid-resident KCs to lose identity and function. Because KC replenishment in rarefied sinusoids would serve little purpose, monocytes follow the formation of collateral vessels that bypass sinusoids, where they form KC-like syncytia that have the capacity to capture bacteria from the bloodstream. Thus, KC maladaptation within an altered fibrotic niche environment is rescued by monocytes forming KC-like syncytia to capture bacteria. These cell structures may play a critical evolutionary role that allows mammals to withstand severe chronic insults in the liver. Kupffer cell adaptation in fibrotic liver disease. In healthy livers, KCs reside in sinusoids and rapidly capture blood-borne pathogens. In liver fibrosis, sinusoids are rarefied, leading to redistributed circulation through high-flow collateral vessels. KCs consequently lose their identity and function. Monocytes then seed larger vessels and form KC-like syncytia with the heightened capacity to capture bacteria, providing a rescue adaptation to the fibrosis-induced loss of KCs.
    Type of Medium: Online Resource
    ISSN: 0036-8075 , 1095-9203
    RVK:
    RVK:
    Language: English
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date: 2023
    detail.hit.zdb_id: 128410-1
    detail.hit.zdb_id: 2066996-3
    detail.hit.zdb_id: 2060783-0
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Neuroinflammation, Springer Science and Business Media LLC, Vol. 20, No. 1 ( 2023-07-28)
    Abstract: Alzheimer’s disease (AD) is an incurable, progressive and devastating neurodegenerative disease. Pathogenesis of AD is associated with the aggregation and accumulation of amyloid beta (Aβ), a major neurotoxic mediator that triggers neuroinflammation and memory impairment. Recently, we found that cellulose ether compounds (CEs) have beneficial effects against prion diseases by inhibiting protein misfolding and replication of prions, which share their replication mechanism with Aβ. CEs are FDA-approved safe additives in foods and pharmaceuticals. Herein, for the first time we determined the therapeutic effects of the representative CE (TC-5RW) in AD using in vitro and in vivo models. Our in vitro studies showed that TC-5RW inhibits Aβ aggregation, as well as neurotoxicity and immunoreactivity in Aβ-exposed human and murine neuroblastoma cells. In in vivo studies, for the first time we observed that single and weekly TC-5RW administration, respectively, improved memory functions of transgenic 5XFAD mouse model of AD. We further demonstrate that TC-5RW treatment of 5XFAD mice significantly inhibited Aβ oligomer and plaque burden and its associated neuroinflammation via regulating astrogliosis, microgliosis and proinflammatory mediator glial maturation factor beta (GMFβ). Additionally, we determined that TC-5RW reduced lipopolysaccharide-induced activated gliosis and GMFβ in vitro. In conclusion, our results demonstrate that CEs have therapeutic effects against Aβ pathologies and cognitive impairments, and direct, potent anti-inflammatory activity to rescue neuroinflammation. Therefore, these FDA-approved compounds are effective candidates for developing therapeutics for AD and related neurodegenerative diseases associated with protein misfolding.
    Type of Medium: Online Resource
    ISSN: 1742-2094
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2023
    detail.hit.zdb_id: 2156455-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...